CARS microscopy of MPIO

send_graphic
Micrometer-sized iron oxide particles (MPIOs) attract increasing interest as contrast agents for cellular tracking by clinical Magnetic Resonance Imaging (MRI). Despite the great potential of MPIOs for in vivo imaging of labeled cells, little is known on the intracellular localization of these particles following uptake due to the lack of techniques with the ability to monitor the particle uptake in vivo at single-cell level. Here, we show that coherent anti-Stokes Raman scattering (CARS) microscopy enables non-invasive, label-free imaging of MPIOs in living cells with sub-micron resolution in three dimensions. CARS allows simultaneous visualization of the cell framework and the MPIOs, where the particles can be readily distinguished from other cellular components of comparable dimensions, and localized inside the cell.
The fruitful cooperation with the FOM Institute AMOLF in Masterdam resulted in the paper "CARS microscopy for the visualization of micrometer-sized iron oxide MRI contrast agents in living cells" (Rago G, Langer CM, Brackman C, Day JP, Domke KF, Raschzok N, Schmidt C, Sauer IM, Enejder A, Mogl MT, Bonn M.) published in Biomed Opt Express. 2011 Sep 1;2(9):2470-83.

Improved cold storage of human hepatocytes

ct
Following a successful project sponsored by the BMBF G. Pless, I.M. Sauer and U. Rauen report on the "Improvement of the cold storage of isolated human hepatocytes" (Cell Transplant. 2011 Jun 7. [Epub ahead of print]).
Increasing amounts of human hepatocytes are needed for clinical applications and different fields of research, such as cell transplantation, bioartificial liver support and pharmacological testing. This demand calls for adequate storage options for isolated human liver cells. As cryopreservation results in severe cryoinjury, short term storage is currently performed at 2-8º C in preservation solutions developed for the storage of solid organs. However, besides slowing down cell metabolism, cold also induces cell injury, which is, in many cell types, iron-dependent and not counteracted by current storage solutions. In this study, we aimed to characterize storage injury to human hepatocytes and develop a customized solution for cold storage of these cells. Human hepatocytes were isolated from material obtained from partial liver resections, seeded in monolayer cultures and, after a pre-culture period, stored in the cold in classical and new solutions followed by rewarming in cell culture medium.Human hepatocytes displayed cold-induced injury, resulting in > 80% cell death (LDH release) after one week of cold storage in University of Wisconsin solution or cell culture medium and 3 h of rewarming. Cold-induced injury could be significantly reduced by the addition of the iron chelators deferoxamine and LK 614. Experiments with modified solutions based on the new organ preservation solution Custodiol-N showed that ion-rich variants were better than ion-poor variants, chloride-rich solutions better than chloride-poor solutions, potassium as main cation superior to sodium and pH 7.0 superior to pH 7.4. LDH release after two weeks of cold storage in the thus optimized solution was below 20%, greatly improving cold storage of human hepatocytes. The results were confirmed by the assessment of hepatocellular mitochondrial membrane potential and functional parameters (resazurin reduction, glucacon-stimulated glucose liberation) and thus suggest the use of a customized hepatocyte storage solution for the cold storage of these cells.

BMBF prize for medical technology awarded

bmbf_logo_en
Today, the BMBF prize (Innovation Competition for Medical Technology) for medical technology was awarded to our joint project with Prof. A. Joerres and Dr. U. Baurmeister concerning the development of a new detoxification system based on our experience with the Single Pass Albumin Dialysis. Research on the technique of diasorption utilising nanoparticles will be funded with approx. 300.000 Euro. More information (in German) here...

BMBF awarded new grant

bmbf_logo
The German Federal Ministry of Education and Research (BMBF – Bundesministerium für Bildung und Forschung) has awarded a grant of nearly 900.000 € for a new collaborative project in tissue engineering: „Methods for hypothermic long term culture of primary human liver cells in perfusion bioreactors“. Partners are Biochrom AG (Dr. R.K. Schindler), Universitätsklinikum Essen, Institut für Physiologische Chemie (Dr. U. Rauen), and Charité – Universitätsmedizin Berlin, Klinik für Allgemein-, Visceral- und Transplantationschirurgie (Dr. I.M. Sauer).

SPAD at Children’s Hospital, Seattle

childrens_logo
In September 2004, the Pharmacy and Therapeutics Committee for Nurses, Pharmacists, and Physicians of the Children’s Hospital and Regional Medical Center in Seattle, USA, approved Single Pass Albumin Dialysis (SPAD) for the support of critically ill patients with liver failure: Children's Medication Update: October 2004 [PDF]

Evaluation of bioreactor systems

AMC2

In vitro comparison test concerning the MELS CellModule and the AMC-BAL are currently performed in cooperation with the Academisch Medisch Centrum (AMC) in Amsterdam...